Page 47 - Query Get News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Children with lupus of all racial and ethnic groups have experienced reduced of end-stage renal disease and dialysis, but the overall improvement has failed to close the outcome gap between Black and white patients, researchers noted.“There’s been a big push in recent years to improve pediatric lupus care, so trending population-based outcomes helps us keep our finger on the pulse to

SEATTLE — Full recovery and functional independence is possible in patients who experience a disorder of consciousness after severe COVID-19 infection, according to a presenter at the 2022 American Academy of Neurology annual meeting. “The reason that this matters is because if you’ve been diagnosed [with minimally conscious state (MCS)], this puts you on a different recovery

Patients with rheumatic and musculoskeletal diseases should engage in both aerobic and strengthening exercises, aiming for at least moderate intensity, according to new EULAR recommendations.The recommendations, which cover lifestyle behaviors and work participation to prevent rheumatic and musculoskeletal disease progression, also state that patients should be counseled that “it is never

Twice-daily Vuity for presbyopia met its primary efficacy endpoint in the phase 3 VIRGO trial, according to a press release from Allergan/AbbVie.Vuity (pilocarpine HCl ophthalmic solution 1.25%) improved near vision without compromising distance vision at hour 9, 3 hours after the second drop, on day 14 of the study, the release said.

WASHINGTON — Treatment with vupanorsen, a novel antisense oligonucleotide targeting hepatic ANGPTL3, achieved modest reductions in non-HDL at 24 weeks at all doses studied, according to results of the TRANSLATE-TIMI 70 trial.Patients assigned vupanorsen at higher doses had increased rates of injection-site reactions, elevations in liver enzymes and dose-related increases in hepatic fat